|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2262833 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09713029.8 |
| Date of filing the European patent application | 2009-02-18 | |
| (97) | Date of publication of the European application | 2010-12-22 |
| (45) | Date of publication and mention of the grant of the patent | 2013-02-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2009/000443 |
| Date | 2009-02-18 |
| (87) | Number | WO 2009/103969 |
| Date | 2009-08-27 |
| (30) | Number | Date | Country code |
| 0802931 | 2008-02-18 | GB |
| (72) |
VINSON, Gavin Paul, GB
BARKER, Stewart, GB
PUDDEFOOT, John, Richard, GB
|
| (73) |
Queen Mary & Westfield College, University of London,
Mile End Road, London E1 4NS,
GB
|
| (54) | SYNTHETIC SCFV ANALOGUE TO THE 6313/G2 (ANTI ANGIOTENSIN II TYPE 1 RECEPTOR) MONOCLONAL ANTIBODY VARIABLE REGIONS |
| SYNTHETIC SCFV ANALOGUE TO THE 6313/G2 (ANTI ANGIOTENSIN II TYPE 1 RECEPTOR) MONOCLONAL ANTIBODY VARIABLE REGIONS |